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In the US, black men are diagnosed with prostate cancer about
70% more often than white men (blacks, 234.4 cases per 100 000;
whites, 135.3 per 100 000); prostate cancer mortality is about
130% greater among black than white men (blacks, 55.5 deaths
per 100 000; whites, 23.8 per 100 000) (National Cancer Institute,
1997). The causes of prostate cancer are only partially understood
and the reasons for the racial differentials in risk are unknown.
Beginning in the 1970s, a series of epidemiological investiga-
tions found that aspects of sexual behaviour are associated with
risk for prostate cancer, suggesting the role of sex hormones or
sexually transmitted diseases (STDs) in the aetiology of prostate
cancer (Ross and Schottenfeld, 1996). The studies, however, were
generally small or had other methodological limitations, so that the
significance of the findings and their interpretation were uncertain
(Nomura and Kolonel, 1991; Ross and Schottenfeld, 1996; Pienta
and Esper, 1993).
Although several STDs occur more frequently among US
blacks than whites (Division of STD Prevention, 1997), only
limited attention has been given to the differential impact of STDs
or other aspects of sexual behaviour on prostate cancer risk in
these populations (Jackson et al, 1980; Ross et al, 1987). We
carried out a large population-based case–control study of prostate
cancer among black and white men in three areas of the US.
Associations with sexual activity and possible exposure to sexu-
ally transmissible agents were evaluated through in-person inter-
views. Serological investigations for selected STDs were carried
out in a subset of the study group.
METHODS
Study design
This case–control study of prostate cancer among US blacks and
whites was conducted as one component of a multi-site study that
also included cancers of the oesophagus and pancreas, and
multiple myeloma. The investigation received Institutional
Review Board approval. Study subjects resided in geographic
areas covered by the population-based cancer registry of the
Georgia Center for Cancer Statistics (Fulton and DeKalb coun-
ties), the Metropolitan Detroit Cancer Surveillance System
(Wayne, Oakland and Macomb counties), and the New Jersey
State Cancer Registry (ten counties).
Questionnaire-based study
Cases for this study were men aged 40–79, identified from
pathology and outpatient records at hospitals covered by these
registries, and newly diagnosed with pathologically confirmed
prostate cancer between 1 August, 1986 and 30 April, 1989.
Identified cases were included for study based upon an age- and
race-stratified sampling scheme to ensure representation of both
blacks and whites in a broad age range. Study cases were classified
by tumour stage (localized or advanced [including regional/
distant]) and grade (well, moderate, or undifferentiated).
Population controls were selected in the three geographic areas
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combined cases for the four cancer sites. Controls younger than 65
years of age were selected by the Waksberg method of random
digit dialling (RDD) (Waksberg, 1978); older controls were
selected by random sampling from the computerized records of the
Health Care Financing Administration.
In total, 1292 cases and 1767 controls were identified for study.
In-person interviews were conducted for the cases and controls,
usually in their homes. Prostate cancer cases and male controls
were questioned about a number of factors, including demo-
graphics, height and weight, occupational history, family history of
cancer, history of sexually transmitted disease, sexual behaviour,
dietary intake, and tobacco and alcohol use. A socio-economic
status score (modified from Green, 1970) was derived from review
of the reported usual occupation. Interviews were obtained for 988
cases (76%; black = 78%, white = 75%) and 1336 controls (76%;
black = 77%, white = 74%). After accounting for non-response in
the initial phase of screening for eligibility among RDD contacts,
the response rate in controls was 70%. Six cases and six controls
were dropped from the analysis due to incomplete interviews.
Sixteen subjects (one case, 15 controls) were excluded due to a
prior history of prostate cancer. The final study group for analysis
of interview data consisted of 981 cases (479 black, 502 white) and
1315 controls (594 black, 721 white) (Table 1). Distributions of
selected variables in this study group are shown in Table 2.
Laboratory-based study
Cases of prostate cancer were eligible for blood collection, which
occurred about 12 weeks after diagnosis, if they had not had
chemotherapy, radiation therapy, treatment with hormone-related
drugs, or orchiectomy prior to blood collection. A series of
controls was also selected for blood collection based on the age
and race distribution of the eligible cases. Venous blood (50 ml)
was drawn and aliquoted to serum, plasma and red blood cell/buffy
coat fractions. Blood products were stored in 1 ml vials at –70°C.
Among interviewed subjects, blood samples were successfully
drawn for serological assays (syphilis and human papillomavirus
(HPV)) from 276 (57%) of the eligible cases and 295 (63%) of the
eligible controls (Table 1).
Specimens were tested in the microhaemagglutination assay for
antibodies to Treponema pallidum (MHA-TP) (Kennedy, 1990).
Serum antibodies to human papillomavirus (HPV-16) were assayed
by a validated enzyme-linked immunosorbent assay (ELISA), with
positive reactivity defined by previously determined optical density
cut-off values (Strickler et al, 1997, 1999). Approximately 85% of
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Table 1 Study subjects
Controls Cases
Black White Total Black White Total
Interviewed subjects 594 721 1315 479 502 981
Eligible for serologic studies 213 254 467 234 251 485
Blood drawn 137 158 295 127 149 276
Table 2 Selected characteristics of interviewed prostate cancer cases and controls.
US blacks US whites
Characteristic Cases Controls Cases Controls
Age
40–59 124 228 164 322
60–69 185 183 157 220
70 + 170 183 181 179
Study area
Atlanta 88 124 103 158
Detroit 180 246 223 268
New Jersey 211 224 176 295
Education
0–8th grade 199 215 55 89
9th–11th grade 118 133 87 97
12th + 161 246 359 529
Alcohol, drinks per week
Never 94 133 90 150
≤7 96 126 136 213
8–21 113 168 140 197
22–56 119 118 92 124
³57 54 48 42 37
Cigarette use
Never used tobacco 88 116 86 149
Current cigarette use 161 221 116 177
Former cigarette use 189 199 243 319
Cancer stage
Localized 268 312
Regional 49 59
Distant 125 73
Unknown 26 42
Total subjects 479 594 502 721individuals who have been infected with T. pallidum will maintain
circulating antibodies that are detectable by the MHA-TP for a
lifetime (Haas et al, 1990). HPV capsid antibodies are also thought
to exhibit long-term persistence (Carter et al, 1996).
Statistical analysis
Odds ratios for prostate cancer were estimated by unconditional
logistic regression (Breslow and Day, 1980). Adjustments for age,
study site (Atlanta, Detroit, New Jersey), and, where appropriate,
race were included in all logistic models. All categories were
defined with common cut points for blacks and whites.
RESULTS
Interview study
Prostate cancer risk was increased among men who had a history
of gonorrhoea or syphilis (OR = 1.6) (Table 3). Risks increased
with increasing number of occurrences of gonorrhoea (P for trend
= 0.0005), rising to odds ratio (OR) = 3.3 among men with three or
more events. The patterns of risk were similar for blacks and
whites; however, these conditions were reported more commonly
among blacks (18.7% vs 2.5% in controls). Greater risk was asso-
ciated with first episodes of gonorrhoea at 20–29 years of age, as
compared to first episodes at younger or older ages. Risks were
similarly elevated among men reporting gonorrhoea only or
syphilis only, but the risks were highest among men reporting both
conditions. Risks associated with these diseases were similar for
all cases combined and for those with advanced (regional/distant)
stage (data not shown).
The risks associated with a history of syphilis or gonorrhea were
highest among men less than 60 years of age at prostate cancer diag-
nosis (blacks, 39 cases, OR = 2.2, 95% confidence interval 
CI 1.3–3.6; whites, nine cases, OR = 1.8, 95% CI 0.7–4.5). The risks
were less pronounced among black men at age 60–69 years (46
cases, OR = 1.5, 95% CI 0.9–2.4) and at age 70+ years (41 cases,
OR = 1.4, 95% CI 0.8–2.4), while no excess risk was found among
white men at age 60–69 years (four cases, OR = 1.0, 95% CI
0.3–4.0) or at age 70+ years (three cases, OR = 0.9, 95% CI
0.2–4.4). Among blacks, the greatest risks were found in Atlanta (31
cases, OR = 7.3; 95% CI 3.2–16.5), with lower risks in New Jersey
(42 cases, OR = 1.5; 95% CI 0.9–2.4) and Detroit (53 cases, OR =
1.1; 95% CI 0.7–1.7). Among whites, the corresponding ORs for the
three study sites were 1.1 (four cases, 95% CI 0.3–4.2), 1.9 (five
cases, 95% CI 0.5–6.8), and 1.2 (seven cases, 95% CI 0.4–3.5).
Although syphilis and gonorrhoea were reported more often
among men of lower SES (14% of controls) than among men of
medium (7.3% of controls) or high SES (4.7% of controls), risks
of prostate cancer associated with these disorders were similar for
men of low (95 cases, OR = 1.5, 95% CI 1.1–2.1), medium (40
cases, OR = 1.6, 95% CI 1.0–2.8), or high SES (seven cases, OR =
1.7, 95% CI 0.6–5.4). The association with history of syphilis or
gonorrhoea was also not changed by statistical adjustment for
education. We previously found associations of prostate cancer in
this study with family history of prostate cancer (Hayes et al,
1995), heavy alcohol use (Hayes et al, 1997), and intake of fat
from animal sources (Hayes et al, 1999), and weaker associations
with cigarette use (Hayes et al, 1994) and vasectomy (Hayes et al,
1993); the association with history of syphilis or gonorrhoea was
independent of these factors.
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Table 3 Risk of prostate cancer among US blacks and whites, by history of sexually transmitted disease
US blacks US whites Total
Characteristic Controls Cases ORa 95% CI Controls Cases ORa 95% CI ORb 95% CI
History of gonorrhoea
Never 485 362 1.0 Referent 693 486 1.0 Referent 1.0 Referent
Ever 103 115 1.6 1.2–2.2 18 15 1.4 0.7–2.9 1.5 1.1–2.0
(%) ever (17.5) (24.1) (2.5) (3.0)
Frequency of gonorrhoea (referent: never)
1 time 68 68 1.4 1.0–2.1 12 12 1.6 0.7–3.7 1.4 1.0–1.9
2 23 26 1.7 0.9–3.1 4 2 1.0 0.2–5.5 1.5 0.9–2.6
3 + 8 19 3.5 1.4–8.3 3.3 1.4–7.8
P for trend 0.0003 0.45 0.0005
Age first had gonorrhoea (referent: never)
<20 years 45 38 1.3 0.8–2.2 2 5 5.1 1.0–26.8 1.4 0.9–2.2
20–29 42 67 2.2 1.4–3.4 7 6 1.3 0.4–4.2 2.0 1.4–3.0
30 + 13 10 1.0 0.4–2.3 8 4 0.8 0.2–2.9 0.9 0.4–1.8
History of syphilis
Never 576 451 1.0 Referent 711 500 1.0 Referent 1.0 Referent
Ever 12 26 2.4 1.2–4.9 1 1 2.8 0.2–49.1 2.6 1.3–5.1
(%) ever (2.0) (5.5) (0.1) (0.2)
History of syphilis or gonorrhoea
Never 478 351 1.0 Referent 693 485 1.0 Referent 1.0 Referent
Syphilis only 7 11 1.8 0.7–4.7 0 1 – 2.2 0.9–5.8
Gonorrhoea only 98 100 1.5 1.1–2.1 17 15 1.5 0.7–3.1 1.4 1.1–1.9
Both 5 15 3.9 1.4–11.0 1 0 – 3.3 1.3–8.7
Syphilis or gonorrhea 110 126 1.7 1.2–2.2 18 16 1.6 0.8–3.2 1.6 1.2–2.1
(%) either condition (18.7) (26.4) (2.5) (3.2)
aOdds ratios, adjusted for age and study site. bOdds ratios, adjusted for age, study site, and race.Long-term use of condoms was associated with decreased 
risk of prostate cancer (Table 4). Risks were increased among 
men who had frequent encounters with prostitutes or who failed 
to use condoms with prostitutes. Number of sexual partners 
(Ptrend < 0.0001) and frequency of encounters with prostitutes 
(Ptrend < 0.0001) were strongly associated with a reported history of
syphilis or gonorrhoea (data not shown). However, the number of
sexual partners was unrelated to prostate cancer risk. Risks were
elevated among never-married black men (OR = 2.2; 95% CI
1.1–4.4) and among white men who had three or more marriages
(OR = 1.8; 95% CI 1.0–3.4). Number of children was unrelated to
risk. When assessed together in a multivariate model, risks for
prostate cancer associated with history of syphilis or gonorrhoea,
sexual encounters with prostitutes, years of condom use and
number of sexual partners remained substantially unchanged.
No clear patterns of risk were associated with age at first sexual
intercourse. Although the frequency of intercourse was not consis-
tently associated with risk, there was a suggestive relationship in
some age groups, notably with frequency of intercourse in the fifth
decade (Table 5). However, many subjects failed to report on
frequency of intercourse.
Serological study
Prostate cancer risk was increased among men with serologic
evidence of infection with T. pallidum (OR = 1.8; 95% CI
1.0–3.5), particularly among blacks (Table 6). The evidence
linking HPV-16 serology to prostate cancer was weaker (OR = 1.4;
95% CI 0.7–2.8), and derived mainly from excess risks among
white men. Syphilis serology was associated with reported number
of sexual partners (Ptrend = 0.009) and with frequency of encounters
with prostitutes (Ptrend = 0.03). HPV serology, however, was not
clearly related to these factors (Ptrend = 0.14 and Ptrend = 0.49,
respectively). Serological evidence of syphilis (9.9% in black and
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Table 4 Risk of prostate cancer among US blacks and whites, by selected characteristics
Characteristic US blacks US whites Total
Cases ORa 95% CI Cases ORa 95% CI ORb 95% CI
Number of marriages
Never 25 2.2 1.1–4.4 17 1.0 0.5–2.0 1.4 0.9–2.2
1 251 1.0 Referent 363 1.0 Referent 1.0 Referent
2 145 1.4 1.1–2.0 87 1.2 0.9–1.6 1.3 1.1–1.6
3+ 35 0.9 0.5–1.4 23 1.8 1.0–3.4 1.0 0.7–1.5
P for trend (excludes never married) 0.42 0.05 0.10
Number of children
None 86 1.0 Referent 67 1.0 Referent 1.0 Referent
1 67 1.1 0.7–1.7 56 0.9 0.6–1.5 1.0 0.7–1.4
2–3 148 0.8 0.6–1.2 251 0.9 0.6–1.3 0.9 0.7–1.1
4–5 96 0.9 0.6–1.4 93 0.9 0.6–1.3 0.9 0.7–1.2
6 + 77 0.8 0.5–1.2 34 1.0 0.5–1.7 0.9 0.6–1.2
P for trend 0.26 0.72 0.32
Number of female sexual partners
<5 88 1.0 Referent 263 1.0 Referent 1.0 Referent
5–9 81 1.1 0.7–1.6 86 1.5 1.1–2.2 1.3 1.0–1.7
10–19 83 1.2 0.8–1.8 52 1.1 0.7–1.6 1.2 0.9–1.5
20–39 72 1.4 0.9–2.2 40 1.4 0.9–2.2 1.4 1.1–2.0
40 + 83 1.2 0.8–1.8 28 1.2 0.7–2.0 1.2 0.9–1.6
P for trend 0.27 0.29 0.17
Sexual encounters with prostitutes
Never 277 1.0 Referent 360 1.0 Referent 1.0 Referent
<5 58 1.1 0.7–1.6 55 1.2 0.8–1.8 1.1 0.8–1.4
5–9 21 1.0 0.5–1.9 12 1.3 0.6–2.8 1.1 0.7–1.8
10–19 25 1.8 0.9–3.4 17 1.1 0.6–2.2 1.4 0.9–2.2
20–39 10 0.8 0.3–1.8 5 1.6 0.4–6.5 1.0 0.5–2.0
40 + 17 1.6 0.7–3.5 15 4.2 1.5–11.9 2.3 1.3–4.2
P for trend 0.27 0.004 0.007
Years used a condom
Never 322 1.0 Referent 352 1.0 Referent 1.0 Referent
1–10 43 1.0 0.7–1.7 30 1.1 0.7–1.9 1.1 0.8–1.6
11–20 10 0.4 0.2–0.9 31 1.8 1.0–3.1 1.0 0.6–1.6
21–30 16 0.9 0.4–1.8 24 0.7 0.4–1.2 0.8 0.5–1.2
30 + 13 0.4 0.2–1.0 21 0.7 0.4–1.2 0.6 0.4–0.9
P for trend 0.02 0.20 0.009
Use of condoms with prostitutes
Never visited prostitutes 277 1.0 Referent 360 1.0 Referent 1.0 Referent
Usually used condoms 47 1.0 0.6–1.5 36 1.1 0.7–1.7 1.0 0.7–1.4
Usually didn’t use condoms 87 1.4 0.9–1.9 68 1.6 1.1–2.3 1.4 1.1–1.8
P for trend 0.13 0.03 0.01
aOdds ratios, adjusted for age and study site. bOdds ratios, adjusted for age, study site and race.3.2% in white controls, Table 6) was more common than self-
reports (2% in black and 0.1% in white controls, Table 3). Among
subjects who replied to the question on history of syphilis and for
whom serology results were available (268 cases, 280 controls),
three (23%) of 13 reports of syphilis were confirmed by MHA-TP
serology, while 42 (7.9%) of 535 subjects who reported no history
of syphilis were serology-positive.
DISCUSSION
Our large population-based case–control study among US blacks
and whites revealed an elevated risk of prostate cancer among men
with a history of gonorrhoea or syphilis. Although STDs are not
considered an established risk factor for prostate cancer (Nomura
and Kolonel, 1991; Pienta and Esper, 1993; Ross and
Schottenfeld, 1996), the results from several (Steele et al, 1971;
Krain, 1974; Heshmat et al, 1975; Lees et al, 1985; Mishina et al,
1985; Mandel and Schuman, 1987; Ross et al, 1987; Honda et al,
1988), but not all previous studies (Wynder et al, 1971) are consis-
tent with our findings. We also observed a greater prevalence of
antibodies to T. pallidum among prostate cancer cases than
controls, suggesting that recall or reporting bias can not entirely
explain the relationship with STDs observed in retrospective inter-
view studies.
The role of sexually transmitted factors in our study is
suggested also by the excess risks of prostate cancer associated
with frequent encounters with prostitutes and with failure to use
condoms. Although some investigations have reported an
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Table 5 Risk of prostate cancer among US blacks and whites, by patterns of sexual intercourse
US blacks US whites Total
Characteristic Cases ORa 95% CI Cases ORa 95% CI ORb 95% CI
Age of first sexual intercourse
<16 166 1.0 Referent 67 1.0 Referent 1.0 Referent
16–19 208 0.8 0.6–1.1 207 0.8 0.5–1.2 0.8 0.7–1.0
20–24 35 0.8 0.5–1.4 134 0.6 0.4–1.0 0.7 0.5–1.9
25–45 4 1.1 0.2–4.9 60 0.8 0.5–1.3 0.9 0.6–1.3
P for trend 0.34 0.27 0.18
Frequency of sexual intercourse in 20 s
<1/week 48 1.0 Referent 84 1.0 Referent 1.0 Referent
1–2/week 101 1.0 0.6–1.3 127 1.1 0.7–1.6 1.0 0.8–1.4
>2–4/week 132 1.5 1.0–2.4 146 1.2 0.8–1.8 1.3 1.0–1.8
>4/week 104 1.4 0.9–2.3 84 0.9 0.6–1.4 1.1 0.8–1.5
unknown 94 1.0 0.6–1.7 61 0.5 0.3–0.8 0.7 0.5–1.0
P for trend 0.09 0.57 0.52
Frequency of sexual intercourse in 30 s
<1/week 25 1.0 Referent 31 1.0 Referent 1.0 Referent
1–2/week 119 1.2 0.7–2.2 136 0.9 0.5–1.5 1.1 0.7–1.5
>2–4/week 151 1.7 1.0–3.0 186 1.2 0.7–2.1 1.4 1.0–2.1
>4/week 89 1.6 0.9–2.8 87 1.1 0.7–2.0 1.3 0.9–2.0
unknown 95 1.2 0.7–2.2 62 0.5 0.3–0.8 0.8 0.5–1.2
P for trend 0.23 0.31 0.12
Frequency of sexual intercourse in 40 s
<1/week 35 1.0 Referent 53 1.0 Referent 1.0 Referent
1–2/week 153 1.2 0.7–1.9 178 0.8 0.5–1.2 0.9 0.7–1.3
>2–4/week 145 1.9 1.1–3.1 159 1.1 0.7–1.6 1.4 1.0–1.9
>4/week 49 1.2 0.7–2.2 53 1.3 0.8–2.2 1.2 0.8–1.7
unknown 97 1.2 0.7–2.0 59 0.4 0.2–0.6 0.7 0.5–1.0
P for trend 0.48 0.09 0.10
Frequency of sexual intercourse in 50 s
<1/week 78 1.0 Referent 96 1.0 Referent 1.0 Referent
1–2/week 203 1.1 0.8–1.6 213 1.1 0.8–1.6 1.1 0.9–1.4
>2/week 93 1.3 0.9–2.0 106 1.6 1.1–2.4 1.5 1.1–2.0
unknown 105 1.0 0.7–1.5 87 0.5 0.4–0.8 0.8 0.6–1.0
P for trend 0.20 0.01 0.005
Frequency of sexual intercourse in 60 s 
(limited to men 60 + years of age)
none 30 1.0 Referent 61 1.0 Referent 1.0 Referent
<1/month 70 1.0 0.5–1.9 47 0.4 0.2–0.7 0.6 0.4–0.9
<1/week 33 0.9 0.4–1.8 35 0.5 0.3–1.0 0.6 0.4–1.0
1–2/week 116 1.0 0.6–1.8 122 0.7 0.4–1.1 0.8 0.5–1.1
>2/week 23 0.6 0.3–1.3 23 0.5 0.3–1.1 0.5 0.3–0.9
unknown 83 0.9 0.5–1.7 50 0.3 0.2–0.5 0.5 0.3–0.7
P for trend 0.17 0.74 0.26
aOdds ratios, adjusted for age and study site. bOdds ratios, adjusted for age, study site and race. P for trend excludes unknowns.increased risk associated with number of sexual partners (Steele et
al, 1971; Krain, 1974; Anderson et al, 1996), no relationship was
seen in our study as well as others (Rotkin, 1977; Mandel and
Schuman, 1987; Honda et al, 1988; La Vecchia et al, 1993). It is
unclear why excess risks have been associated with a history of
STDs but not consistently with number of sexual partners, raising
the possibility that STD-associated prostate cancer is confined to a
subset of the sexually active population, in which ecological
factors as well as individual behaviours influence transmission of
an infectious agent (Koopman and Longini, 1994; Brunham and
Plummer, 1990).
Gonorrhoea and syphilis were reported substantially more often
among blacks (18.7%) than whites (2.5%) in our study, consistent
with reports from national surveillance data systems (Nakashima
et al, 1996; Division of STD Prevention, 1997). However, the
fraction of prostate cancer associated with syphilis or gonorrhoea
(9.5% in blacks, 0.7% in whites) would account (assuming a
causal relation) for a relatively small per cent of the black-white
difference in cancer rates.
Since gonorrhoea and syphilis may be sentinels for a sexually
transmitted infectious agent that contributes to the aetiology of
prostate cancer, the risks we observed for STDs would only
partially reflect the true risks associated with the putative agent.
For example, only after sensitive and specific assays were devel-
oped for HPV did the relatively modest risks for cervical intra-
epithelial neoplasia associated with sexual activity (two- to
fourfold) translate to the substantial (50-fold) risks now estab-
lished for cervical disease due to specific HPV subtypes
(Schiffman et al, 1993). Although estimates of relative risk for
prostate cancer were fairly consistent when measured by various
definitions of sexually transmitted disease, population attributable
risks remain uncertain as the prevalence estimates for STDs in our
study varied substantially by disease type and by whether the
method of ascertainment was by questionnaire or serology. Both
questionnaire and serological measures are subject to measure-
ment error (Romanowski et al, 1991; Anderson et al, 1994).
Although subgroup analyses in our study were limited by small
numbers, the risks associated with history of STDs were greatest
among younger men (< 60 years of age) and among black men in
Atlanta. The age effect may indicate differential susceptibility or
perhaps greater misclassification of these conditions among older
men. More intriguing is the geographic variation in view of the
high prevalence of gonorrhoea and syphilis in the southeastern
States (Thomas et al, 1996; Kilmarx et al, 1997), as well as the
elevated prostate cancer mortality rates among black men in this
region (Devesa et al, 1999). Although STDs are more common
among men of lower social class (Nakashima et al, 1996; Kilmarx
et al, 1997), the relative risks for prostate cancer in our study did
not vary by measures of SES, suggesting that the STD-associated
risks are not simply an indicator of SES-related factors.
Microbiological and molecular studies to detect infectious
agents that may induce prostate cancer have been inconclusive.
HPV, which occurs in human prostate cancer and benign prostatic
tissue (Cuzick, 1995; IARC, 1995), has been shown to transform
human prostate cells in vitro. Seropositivity for HPV-18 and HPV-
16 has been associated with subsequent prostate cancer in a
Finnish cohort study (Dillner et al, 1998), but a small case–control
study of HPV-16 and HPV-11 (Strickler et al, 1998), and our sero-
logical investigation of HPV-16 showed little evidence of risk.
Since HPV seropositivity is low in these studies (e.g. HPV-16 
< 5%), larger investigations will be needed to clarify this relation-
ship. While an excess of prostate cancer has been observed in men
with anal cancer, which is linked to HPV infection (IARC, 1995),
the epidemiological patterns of HPV-related cervical cancer
(Schiffman et al, 1996) are not closely correlated with prostate
cancer, although one study reported increased occurrence of
cervical cancer in spouses of prostate cancer patients (Feminella
and Lattimer, 1974). In addition, no case–control differences have
been found with serological responses to herpes simplex,
cytomegalovirus and Epstein–Barr virus (Baker et al, 1981;
Mandel and Schuman, 1987; Anderson et al, 1996), and studies of
HHV8 RNA transcripts in prostate tumour tissue have been incon-
clusive (Staskus et al, 1997).
Our findings should not be viewed as inconsistent with the
widely held view that androgen metabolism plays an important
role in prostate carcinogenesis, and that underlying hormonal
factors may contribute to the relationship between sexual behav-
iour, STDs and prostate cancer risk. However, frequency of sexual
intercourse was not clearly associated with prostate cancer risk in
our study, as one might expect if hormonal factors were respon-
sible for the relationships observed. Furthermore, the association
between serum hormone levels and sexual activity among men
with normal gonads is uncertain (Buena et al, 1993; Mantzoros et
al, 1995; Bagatell and Bremmer, 1997).
Further insight into the relationship between sexual behaviour
and prostate cancer, and the mechanisms involved, may come from
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Table 6 Serological characteristics and risk of prostate cancer among US blacks and whites
US blacks US whites Total
Characteristic Controls Cases ORa 95% CI Controls Cases ORa 95% CI ORb 95% CI
Antibodies to syphillis
Non-reactive 118 98 1.0 Referent 149 143 1.0 Referent 1.0 Referent
Minimally reactive 0 1 – 1 0 – 1.2 0.1–19.4
Reactive 13 26 2.2 1.0–4.6 5 3 0.8 0.2–3.5 1.8 1.0–3.5
(%) reactive (9.9) (20.8) (3.2) (2.1)
Antibodies to HPV 16
Negative 120 116 1.0 Referent 144 132 1.0 Referent 1.0 Referent
Indeterminate 5 3 0.7 0.1–3.1 5 4 0.8 0.2–3.3 0.8 0.3–2.1
Positive 8 8 1.0 0.3–2.8 7 11 1.8 0.7–4.9 1.4 0.7–2.8
(%) positive (6.3) (6.3) (4.6) (7.5)
aOdds ratios, adjusted for age and study site. bOdds ratios, adjusted for age, study site, and race.prospective epidemiological studies that employ hormonal, micro-
bial and other potential biomarkers of risk. Although a search for
infectious agents in unselected prostate tumour tissue has been
uninformative to date, study of tumour tissue from men with a
history of STDs might prove useful.
In summary, our case–control study of prostate cancer among
US blacks and whites revealed excess risks among men who
reported a history of gonorrhoea or syphilis, had a positive
serology for syphilis, or reported certain sexual behaviours that
predispose to these conditions. Although a history of STDs
appears associated with a relatively small number of prostate
cancers, the findings suggest the need to expand the search for a
sexually transmitted agent as well as hormonal and other factors
that may contribute to the aetiology of these tumours.
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